<DOC>
	<DOCNO>NCT02678286</DOCNO>
	<brief_summary>The primary objective study evaluate analgesic efficacy N1539 subject acute moderate severe pain follow abdominoplasty surgery .</brief_summary>
	<brief_title>Evaluation N1539 Following Abdominoplasty Surgery</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Meloxicam</mesh_term>
	<criteria>Voluntarily provide write informed consent . Male female 18 75 year age , inclusive . Be schedule undergo elective abdominoplasty surgery without collateral procedure . Be American Society Anesthesiology ( ASA ) physical class 1 2 . Female subject eligible follow apply : Not pregnant ; Not lactate ; Not plan become pregnant study ; Commit use acceptable form birth control duration study . Have body mass index ≤35 kg/m2 Be able understand study procedure , comply study procedure , agree participate study program . Have know allergy meloxicam excipient N1539 , D5W , aspirin , nonsteroidal antiinflammatory drug ( NSAIDs ) peri postoperative medication use study . Have clinically significant abnormal clinical laboratory test value . Have history positive test result HIV , hepatitis B C. Have history clinical manifestation significant renal , hepatic , cardiovascular , metabolic , neurologic , psychiatric , condition would preclude participation study . Have history myocardial infarction coronary artery bypass graft surgery within precede 12 month Have history migraine frequent headache , seizure , currently take anticonvulsant . Have active recent ( within 6 month ) gastrointestinal ulceration bleeding . Have know bleeding disorder take agent affect coagulation . Have another painful physical condition may confound assessment post operative pain . Have evidence clinically significant 12 lead ECG abnormality . Have history alcohol abuse ( regularly drink &gt; 4 unit alcohol per day ; 8 oz . beer , 3 oz . wine , 1 oz . spirit ) within past 5 year history prescription/illicit drug abuse . Have positive result urine drug screen alcohol breath test indicative illicit drug alcohol abuse . Have receive receive chronic opioid therapy define great 15 morphine equivalent unit per day great 3 7 day per week onemonth period within 12 month surgery . Use concurrent therapy could interfere evaluation efficacy safety , drug investigator 's opinion may exert significant analgesic property act synergistically N1539 . Unable discontinue medication , stable dose least 14 day prior schedule bunionectomy procedure , within 5 half life specific prior medication ( , half life know , within 48 hour ) dose study medication . Have utilized corticosteroid , either systemically intraarticular injection , within 6 week prior surgical procedure . Have receive investigational product within 30 day dose study medication . Be receive warfarin , lithium , combination furosemide either angiotensin convert enzyme inhibitor angiotensin receptor blocker Be currently receive treatment oral meloxicam ( Mobic® ) within 7 day prior surgery Have previously receive N1539 clinical trial , major surgery last 3 month would interfere study outcomes increase risk study participation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Abdominoplasty</keyword>
	<keyword>Pain</keyword>
	<keyword>Analgesia</keyword>
	<keyword>N1539</keyword>
	<keyword>Phase 3</keyword>
</DOC>